Early Stage

Minimize Discomfort, Maximize Life

Minimize Discomfort, Maximize Life


Raised this Round: Raised: $47,614

Total Commitments ($USD)



Start Date


Close Date


Min. Goal
Max. Goal
Min. Investment


Security Type

Equity - Common

SEC Filing Type

RegCF    Open SEC Filing

Price Per Share


Pre-Money Valuation


Year Founded



Fitness & Wellness

Tech Sector


Los Angeles, California

Nannocare, the manufacturer of revolutionary menstrual products, is raising crowdfunding on StartEngine. The company has a pre-money valuation of $14.8 million and uses Nannogenic technology to create alternatives to outdated menstrual products. The technology of Nannocare uses far-infrared rays, generated by the body itself, to improve blood circulation and relieve discomfort during menstruation. Nannocare was founded by Paul Van Kleef in 2017. The current crowdfunding round has a minimum target of $10,000 and a maximum target of $107,000. Nannocare is led by a team of highly experienced gynecologists, and the technology has been used and proven by many users in users testings. NannoPads and other products of Nannocare were sold at over 5,000 locations, with a 95% reorder rate in the last quarter.
Create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)


$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.
Add to portfolio
Nannocare on StartEngine
Platform: StartEngine
Security Type: Equity - Common
Valuation: $14,800,000
Price per Share: $2.47

Follow company

Follow Nannocare on StartEngine

Buy Nannocare's Deal Report

Warning: according to the close date for this deal, Nannocare may no longer be accepting investments.

Nannocare Deal Report

Get KingsCrowd’s comprehensive report on Nannocare including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether Nannocare is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the Nannocare deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge